Cholesterol-lowering drug could help fight prostate cancer

Cholesterol-lowering drug could help fight prostate cancer

An experimental drug designed to lower cholesterol may turn out to be an effective weapon against prostate cancer, research has shown.

Tumour cells need cholesterol to construct their cell membranes. By cutting their cholesterol production, the new molecule, known as RO 48-8071, causes the cells to fall apart and die.

It could also have the added benefit of preventing prostate cancer developing resistance to hormone therapies.

Professor Salman Hyder, from the University of Missouri in the US, said: "Cholesterol is a molecule found in animal cells that serves as a structural component of cell membranes. When tumour cells grow, they synthesise more cholesterol.

"Often, cancer patients are treated with toxic chemotherapies; however, in our study, we focused on reducing the production of cholesterol in cancer cells, which could kill cancer cells and reduce the need for toxic chemotherapy."

The compound was originally developed by the drug company Roche for the treatment of high cholesterol.

Prof. Hyder's team found that human prostate cancer cells exposed to the drug in the laboratory died.

When the drug was injected into mice with human prostate cancer, tumour growth was curbed.

Importantly, the drug appeared to be effective against prostate cancer cells that had become resistant to hormone treatments.

Prostate cancer is initially tackled by preventing its growth being fuelled by the male hormone testosterone. But over time, the cancer stops responding to this treatment.

One way tumours ensure their survival is by manufacturing their own testosterone through a process that relies on cholesterol.

"Cholesterol ... can contribute to the development of anti-hormone resistance because cholesterol is converted into hormones in tumour cells," said Prof Hyder. "Therefore, these cholesterol-forming pathways are attractive therapeutic targets for the treatment of prostate cancer."

The study is due to appear in the journal OncoTargets and Therapy.

More in this Section

US state of Virginia marks 400th anniversary of slave ship arrivalUS state of Virginia marks 400th anniversary of slave ship arrival

Johnson’s first summit as PM sees clash with Tusk over Brexit blameJohnson’s first summit as PM sees clash with Tusk over Brexit blame

Tusk and Johnson clash over who will be to blame in case of no-deal BrexitTusk and Johnson clash over who will be to blame in case of no-deal Brexit

Prince Andrew insists he never suspected paedophile Jeffrey EpsteinPrince Andrew insists he never suspected paedophile Jeffrey Epstein


Lifestyle

In August 1969, headlines were dominated by Northern Ireland and the beginnings of what was to become known as “the Troubles”.August 26, 2019: A look back at what happened on this day in years gone by

Hundreds of grey seals, the ‘people of the sea’, haul out on Great Blasket’s Trá Bán.Blasket Island seals have cousins in Namibia

More From The Irish Examiner